1. Ann Arbor pharmaceutical company acquires nasal spray treatment manufacturer  MLive.com
  2. Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio  The Globe and Mail
  3. Esperion Adds $25 Million Term Loans, Sells $50 Million Otsuka Royalties to Fund Corstasis Buy  TradingView
  4. Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)  Yahoo Finance
  5. Esperion completes acquisition of Corstasis Therapeutics  Investing.com